Erratum to: Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2) (The FASEB Journal, (2014), 28, 1, (300-315), 10.1096/fj.13-237743);Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2)

FASEB Journal

Volumn 28, Issue 1, 2014, Pages 300-315

  Lamming, Dudley W ^a,b   Demirkan, Gokhan ^c,e,f   Boylan, Joan M ^d,e   Mihaylova, Maria M ^a,b   Peng, Tao ^a,b,g   Ferreira, Jonathan ^c   Neretti, Nicola ^c   Salomon, Arthur ^c   Sabatini, David M ^a,b   Gruppuso, Philip A ^c,d,e  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BROWN UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

^e RHODE ISLAND HOSPITAL   (United States)

^f ARIZONA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Liver; Metabolism; Proteomics; Signal transduction

Indexed keywords

ACYLTRANSFERASE; ANDROGEN RECEPTOR; CELL ADHESION MOLECULE; CYP2A12; CYTOCHROME P450; CYTOCHROME P450 2C9; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; GLUCOSE 6 PHOSPHATASE; LEPTIN RECEPTOR; LIPID; LIPOCALIN; LIVER PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; N ACYLTRANSFERASE 8; NCAM2 PROTEIN; PHOSPHOPROTEOME; PROTEASOME; RAET1D PROTEIN; RAPAMYCIN; RECEPTOR; REGULATOR OF G PROTEIN SIGNALING 16; RETINOIC ACID; RGS PROTEIN; SLC10A2 PROTEIN; SODIUM BILE ACID COTRANSPORTER; SUCCINATE RECEPTOR 1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTOME; UNCLASSIFIED DRUG; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; FETUS; FETUS CELL; GENE EXPRESSION; GENOMICS; IMMUNOBLOTTING; LIPID METABOLISM; LIVER CELL; LIVER CELL CULTURE; LIVER HOMOGENATE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHOPROTEOMICS; PRIORITY JOURNAL; PROTEASOMAL BIOGENESIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOMAL BIOGENESIS; RIBOSOME; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM;

GENE EXPRESSION; LIVER; METABOLISM; PROTEOMICS; SIGNAL TRANSDUCTION;

ANIMALS; LIVER; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; PROTEOMICS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84894225988     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fsb2.21165     Document Type: Erratum

References (51)

1. Crespo, J. L., Diaz-Troya, S., and Florencio, F. J. (2005) Inhibition of target of rapamycin signaling by rapamycin in the unicellular green alga Chlamydomonas reinhardtii. Plant Physiol. 139, 1736-1749
2. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E., and Miller, R. A. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395
3. Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., Orihuela, C. J., Pletcher, S., Sharp, Z. D., Sinclair, D., Starnes, J. W., Wilkinson, J. E., Nadon, N. L., and Strong, R. (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191-201
4. Robida-Stubbs, S., Glover-Cutter, K., Lamming, D. W., Mizunuma, M., Narasimhan, S. D., Neumann-Haefelin, E., Sabatini, D. M., and Blackwell, T. K. (2012) Tor signaling and rapamycin influence longevity by regulating skn-1/nrf and daf-16/foxo. Cell Metab. 15, 713-724
5. Laplante, M., and Sabatini, D. M. (2012) Mtor signaling in growth control and disease. Cell 149, 274-293
6. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., and Sabatini, D. M. (2006) Prolonged rapamycin treatment inhibits mtorc2 assembly and akt/pkb. Mol. Cell 22, 159-168
7. Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., Guertin, D. A., Sabatini, D. M., and Baur, J. A. (2012) Rapamycin-induced insulin resistance is mediated by mtorc2 loss and uncoupled from longevity. Science 335, 1638-1643
8. Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M. H., Ruegg, M. A., and Hall, M. N. (2012) Hepatic mtorc2 activates glycolysis and lipogenesis through akt, glucokinase, and srebp1c. Cell Metab. 15, 725-738
9. Yuan, M., Pino, E., Wu, L., Kacergis, M., and Soukas, A. A. (2012) Identification of akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mtor) complex 2. J. Biol. Chem. 287, 29579-29588
10. Guertin, D. A., Stevens, D. M., Saitoh, M., Kinkel, S., Crosby, K., Sheen, J. H., Mullholland, D. J., Magnuson, M. A., Wu, H., and Sabatini, D. M. (2009) Mtor complex 2 is required for the development of prostate cancer induced by pten loss in mice. Cancer Cell 15, 148-159
11. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299
12. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., Houstis, N., Daly, M. J., Patterson, N., Mesirov, J. P., Golub, T. R., Tamayo, P., Spiegelman, B., Lander, E. S., Hirschhorn, J. N., Altshuler, D., and Groop, L. C. (2003) Pgc-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273
13. Subramanian, A., Kuehn, H., Gould, J., Tamayo, P., and Mesirov, J. P. (2007) Gsea-p: a desktop application for gene set enrichment analysis. Bioinformatics 23, 3251-3253
14. Demirkan, G., Yu, K., Boylan, J. M., Salomon, A. R., and Gruppuso, P. A. (2011) Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mtorc1). PLoS One 6, e21729
15. Yu, K., and Salomon, A. R. (2010) Htapp: high-throughput autonomous proteomic pipeline. Proteomics 10, 2113-2122
16. Ficarro, S. B., Salomon, A. R., Brill, L. M., Mason, D. E., Stettler-Gill, M., Brock, A., and Peters, E. C. (2005) Automated immobilized metal affinity chromatography/nano-liquid chromatography/ electrospray ionization mass spectrometry platform for profiling protein phosphorylation sites. Rapid Commun. Mass Spectrom. 19, 57-71
17. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567
18. Elias, J. E., and Gygi, S. P. (2010) Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol. Biol. 604, 55-71
19. Beausoleil, S. A., Villen, J., Gerber, S. A., Rush, J., and Gygi, S. P. (2006) A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285-1292
20. Festuccia, W. T., Blanchard, P. G., Richard, D., and Deshaies, Y. (2010) Basal adrenergic tone is required for maximal stimulation of rat brown adipose tissue ucp1 expression by chronic ppar-gamma activation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R159-R167
21. Mihaylova, M. M., Vasquez, D. S., Ravnskjaer, K., Denechaud, P. D., Yu, R. T., Alvarez, J. G., Downes, M., Evans, R. M., Montminy, M., and Shaw, R. J. (2011) Class iia histone deacetylases are hormone-activated regulators of foxo and mammalian glucose homeostasis. Cell 145, 607-621
22. Lee, J., Sun, C., Zhou, Y., Gokalp, D., Herrema, H., Park, S. W., Davis, R. J., and Ozcan, U. (2011) P38 mapk-mediated regulation of xbp1s is crucial for glucose homeostasis. Nat. Med. 17, 1251-1260
23. Zhang, Y., Xu, P., Park, K., Choi, Y., Moore, D. D., and Wang, L. (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin d1 expression and cellular proliferation. Hepatology 48, 289-298
24. Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J. M., and Stoffel, M. (2004) Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027-1032
25. Haeusler, R. A., Kaestner, K. H., and Accili, D. (2010) Foxos function synergistically to promote glucose production. J. Biol. Chem. 285, 35245-35248
26. Duvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., Vander Heiden, M. G., MacKeigan, J. P., Finan, P. M., Clish, C. B., Murphy, L. O., and Manning, B. D. (2010) Activation of a metabolic gene regulatory network downstream of mtor complex 1. Mol. Cell 39, 171-183
27. Steinbaugh, M. J., Sun, L. Y., Bartke, A., and Miller, R. A. (2012) Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan. Am. J. Physiol. Endocrinol. Metab. 303, E488-E495
28. Laplante, M., Festuccia, W. T., Soucy, G., Gelinas, Y., Lalonde, J., Berger, J. P., and Deshaies, Y. (2006) Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes 55, 2771-2778
29. Oh, W. J., and Jacinto, E. (2011) Mtor complex 2 signaling and functions. Cell Cycle 10, 2305-2316
30. Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., Marto, J. A., and Sabatini, D. M. (2011) The mtor-regulated phosphoproteome reveals a mechanism of mtorc1-mediated inhibition of growth factor signaling. Science 332, 1317-1322
31. Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., and Hall, M. N. (2013) Quantitative phosphoproteomics reveal mtorc1 activates de novo pyrimidine synthesis. Science 339, 1320-1323
32. Ben-Sahra, I., Howell, J. J., Asara, J. M., and Manning, B. D. (2013) Stimulation of de novo pyrimidine synthesis by growth signaling through mtor and s6k1. Science 339, 1323-1328
33. Cuadrado, A., and Nebreda, A. R. (2010) Mechanisms and functions of p38 mapk signalling. Biochem. J. 429, 403-417
34. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M. A., Hall, A., and Hall, M. N. (2004) Mammalian tor complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128
35. Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., and Gray, N. S. (2009) An atp-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mtorc1. J. Biol. Chem. 284, 8023-8032
36. Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., and Shokat, K. M. (2009) Active-site inhibitors of mtor target rapamycin-resistant outputs of mtorc1 and mtorc2. PLoS Biol. 7, e38
37. Cohen, S. E., Kokkotou, E., Biddinger, S. B., Kondo, T., Gebhardt, R., Kratzsch, J., Mantzoros, C. S., and Kahn, C. R. (2007) High circulating leptin receptors with normal leptin sensitivity in liver-specific insulin receptor knock-out (lirko) mice. J. Biol. Chem. 282, 23672-23678
38. Hirashima, Y., Tsuruzoe, K., Kodama, S., Igata, M., Toyonaga, T., Ueki, K., Kahn, C. R., and Araki, E. (2003) Insulin downregulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/akt pathway. J. Endocrinol. 179, 253-266
39. Cho, K. W., Zhou, Y., Sheng, L., and Rui, L. (2011) Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Mol. Cell. Biol. 31, 450-457
40. Hu, H., and Li, X. (2007) Transcriptional regulation in eukaryotic ribosomal protein genes. Genomics 90, 421-423
41. Tonner, P., Srinivasasainagendra, V., Zhang, S., and Zhi, D. (2012) Detecting transcription of ribosomal protein pseudogenes in diverse human tissues from rna-seq data. BMC Genomics 13, 412
42. Gruppuso, P. A., Boylan, J. M., and Sanders, J. A. (2011) The physiology and pathophysiology of rapamycin resistance: implications for cancer. Cell Cycle 10, 1050-1058
43. Payne, V. A., Arden, C., Wu, C., Lange, A. J., and Agius, L. (2005) Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes. Diabetes 54, 1949-1957
44. Kurland, I. J., el-Maghrabi, M. R., Correia, J. J., and Pilkis, S. J. (1992) Rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: properties of phospho- and dephospho- forms and of two mutants in which ser32 has been changed by site-directed mutagenesis. J. Biol. Chem. 267, 4416-4423
45. Skurat, A. V., and Roach, P. J. (1995) Phosphorylation of sites 3a and 3b (ser640 and ser644) in the control of rabbit muscle glycogen synthase. J. Biol. Chem. 270, 12491-12497
46. Chun, J., Kwon, T., Kim, D. J., Park, I., Chung, G., Lee, E. J., Hong, S. K., Chang, S. I., Kim, H. Y., and Kang, S. S. (2003) Inhibition of mitogen-activated kinase kinase kinase 3 activity through phosphorylation by the serum- and glucocorticoidinduced kinase 1. J. Biochem. 133, 103-108
47. Asada, S., Daitoku, H., Matsuzaki, H., Saito, T., Sudo, T., Mukai, H., Iwashita, S., Kako, K., Kishi, T., Kasuya, Y., and Fukamizu, A. (2007) Mitogen-activated protein kinases, erk and p38, phosphorylate and regulate foxo1. Cell. Signal. 19, 519-527
48. Clavel, S., Siffroi-Fernandez, S., Coldefy, A. S., Boulukos, K., Pisani, D. F., and Derijard, B. (2010) Regulation of the intracellular localization of foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells. Mol. Cell. Biol. 30, 470-480
49. Willems, L., Chapuis, N., Puissant, A., Maciel, T. T., Green, A. S., Jacque, N., Vignon, C., Park, S., Guichard, S., Herault, O., Fricot, A., Hermine, O., Moura, I. C., Auberger, P., Ifrah, N., Dreyfus, F., Bonnet, D., Lacombe, C., Mayeux, P., Bouscary, D., and Tamburini, J. (2012) The dual mtorc1 and mtorc2 inhibitor azd8055 has anti-tumor activity in acute myeloid leukemia. Leukemia 26, 1195-1202
50. Giubellino, A., Bullova, P., Nolting, S., Turkova, H., Powers, J. F., Liu, Q., Guichard, S., Tischler, A. S., Grossman, A. B., and Pacak, K. (2013) Combined inhibition of mtorc1 and mtorc2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice. Endocrinology 154, 646-655
51. Zhou, H. Y., and Huang, S. L. (2012) Current development of the second generation of mtor inhibitors as anticancer agents. Chin. J. Cancer 31, 8-18